Fund Holdings — Enavate Sciences GP, LLC

Total Portfolio Value:
$506.78M
Total Bought:
$58.80M
Total Sold:
$7.25M
Net Transaction:
+$51.55M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Zenas BioPharma, Inc.(ZBIO)3,761,3593,919,159+157,800$83.50M$142.30M28.08%+$58.80M
Immunome, Inc.(IMNM)4,768,5834,768,5830$55.84M$102.43M20.21%+$46.59M
Sionna Therapeutics, Inc.(SION)2,478,0302,478,0300$72.88M$101.95M20.12%+$29.07M
Upstream Bio, Inc.(UPB)2,459,7032,459,7030$46.27M$66.78M13.18%+$20.51M
Compass Therapeutics, Inc.(CMPX)7,788,1507,788,1500$27.26M$41.82M8.25%+$14.56M
BridgeBio Oncology Therapeutics, Inc.(BBOT)2,626,9462,626,9460$30.42M$32.89M6.49%+$2.47M
CAMP4 THERAPEUTICS CORPORATION(CAMP)3,785,8023,035,825-749,977$11.36M$18.61M3.67%+$7.25M
Page 1 of 1